Monitoring Cancer Stem Cells: Insights into Clinical Oncology.
ShuChen Lin,YingChun Xu,ZhiHua Gan,Kun Han,HaiYan Hu,Yang Yao,MingZhu Huang,DaLiu Min
DOI: https://doi.org/10.2147/ott.s96645
IF: 4
2016-01-01
OncoTargets and Therapy
Abstract:Cancer stem cells (CSCs) are a small, characteristically distinctive subset of tumor cells responsible for tumor initiation and progression. Several treatment modalities, such as surgery, glycolytic inhibition, driving CSC proliferation, immunotherapy, and hypofractionated radiotherapy, may have the potential to eradicate CSCs. We propose that monitoring CSCs is important in clinical oncology as CSC populations may reflect true treatment response and assist with managing treatment strategies, such as defining optimal chemotherapy cycles, permitting pretreatment cancer surveillance, conducting a comprehensive treatment plan, modifying radiation treatment, and deploying rechallenge chemotherapy. Then, we describe methods for monitoring CSCs.